ArticleScientific reports2023
Diagnostic performance of SARC-F and SARC-CalF in screening for sarcopenia in older adults in Northern Brazil.
Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Evaluating the Discriminative Performance of SARC-F and SARC-CalF in Identifying Functional Impairment in Community-Dwelling Older Adults.Physiotherapy research international : the journal for researchers and clinicians in physical therapy · 2026Observational
- Differential Effects of Stroke Stage and Age on Sarcopenia in Stroke Patients: A Cross-Sectional Study.Life (Basel, Switzerland) · 2026Article
- Feasibility of social media health education plus exercise in older adults with possible sarcopenia.NPJ digital medicine · 2026Article
- Parker Mobility Score as a Screening Tool for Sarcopenia in Older German Adults: A Cross-Sectional Analysis of Trial Data.Health science reports · 2026Article
- Translation, Cross-Cultural Adaptation, and Validation of the Croatian Version of the SARC-F Questionnaire for Assessing Sarcopenia in Older Adults.Healthcare (Basel, Switzerland) · 2026Article
- Diagnostic accuracy of sarcopenia screening tools in low-income older adults in Amazonas, Brazil.Aging clinical and experimental research · 2025Article
- The Effects of Pulsed Electromagnetic Field (PEMF) on Muscular Strength, Functional Performance and Depressive Symptoms in Elderly Adults with Sarcopenia: A Short-Term Intervention.Life (Basel, Switzerland) · 2025Article
- Risk of sarcopenia in women with breast cancer: a comparative analysis of screening tools.BMC cancer · 2025Observational
- Agreement analysis and associated factors of SARC-F and SARC-CALF in screening of risk sarcopenia in people living with human immunodeficiency virus.Clinics (Sao Paulo, Brazil) · 2025Article
- Evaluating SARC-F, SARC-CalF, and calf circumference as diagnostic tools for sarcopenia in Thai older adults: results from a nationwide study.BMC geriatrics · 2024Observational
- Diagnostic accuracy analysis of SARC-F, its modified versions and the Quality of Life in Sarcopenia questionnaire in screening for sarcopenia in nursing home residents.Geriatrics & gerontology international · 2024Article
- Development and validation of a screening tool for sarcopenia in Chinese nursing home residents.iScience · 2024Article
- Exploring the role of body mass index-adjusted calf circumference within the SARC-CalF screening tool among older patients with cancer.The journal of nutrition, health & aging · 2024Article
- Sarcopenia and Pleural Mesothelioma: The Current Knowledge.Muscles (Basel, Switzerland) · 2024Review
- Clinical considerations for sarcopenia in older Colombian Afro-descendant and mestizo women.The Journal of international medical research · 2023Article
- Analysis of SARC-F and SARCCalF accuracy in assessing sarcopenia risk on older adults with cardiovascular diseases admitted to a referral hospital: A cross-sectional study.Brazilian journal of physical therapyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To compare the performance of SARC-F and SARC-CalF as screening tools for sarcopenia. Cross-sectional study with a convenience sample of 312 community-dwelling older people. Sarcopenia was defined as low handgrip strength (HGS) or low gait speed (GS ≤ 0.8 m/s). HGS was measured by dynamometry and GS by the 4-m walking speed test. For HGS, six criteria (C) were used to identify sarcopenia in men/women: C
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.